Literature DB >> 12162204

[Infectious complications of lymphedema].

L Vaillant1, N Gironet.   

Abstract

Erysipelas and lymphangitis are frequent complications of lymphedemas (20 to 30%). The most important risk factor for erysipelas is lymphedema since this is a protein rich edema that contributes to the risk of infection. In case of lymphedema the treatment is the usual consensus treatment for erysipelas. A prophylactic treatment with penicillin is requested as soon as the first recurrence. This prophylactic treatment includes skin care, particularly treatment of injuries and intertrigos. Hyperplastic skin leads to maceration and then mycoses. Physiotherapy does not increase the risk for infection. Moreover an infection needs a complex decongestive physiotherapy which decreases risks of recurrence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12162204     DOI: 10.1016/s0248-8663(02)80383-6

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  4 in total

1.  Cryptic Bacteria of Lower Limb Deep Tissues as a Possible Cause of Inflammatory and Necrotic Changes in Ischemia, Venous Stasis and Varices, and Lymphedema.

Authors:  Waldemar L Olszewski; Marzanna Zaleska; Ewa Stelmach; Ewa Swoboda-Kopec; Pradeep Jain; Karoon Agrawal; Sashi Gogia; Arun Gogia; Piotr Andziak; Marek Durlik
Journal:  Surg Infect (Larchmt)       Date:  2015-05-26       Impact factor: 2.150

2.  Selenium Deficiency in Lymphedema and Lipedema-A Retrospective Cross-Sectional Study from a Specialized Clinic.

Authors:  Christina Pfister; Horst Dawczynski; Franz-Josef Schingale
Journal:  Nutrients       Date:  2020-04-25       Impact factor: 5.717

3.  Erysipelas on surgical scar: a case report.

Authors:  Asma Korbi; Ahmed Hajji; Hela Dahmani; Farouk Ennaceur; Haifa Bergaoui; Awatef Hajjaji; Raja Faleh
Journal:  Pan Afr Med J       Date:  2020-02-07

Review 4.  [Erysipelas on postoperative scar in traumatology: report of a case and review of literature].

Authors:  Hatim Abid; Mohamed El Idrissi; Mohamed Shimi; Abdelhalim El Ibrahimi; Abdelmajid El Mrini; Nissrine Amraoui; Fatima Zohra Mernissi
Journal:  Pan Afr Med J       Date:  2015-05-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.